Welcome to Sage Perspectives. Browse the latest posts below or explore the categories. Interested in writing for us? Get in touch and let us know your ideas.
The realm of neurological research is witnessing an unprecedented wave of innovation, reshaping our understanding and treatment of complex disorders. From gene therapy to brain-computer interfaces, the scope of advancements is broad, each promising a brighter future for patients worldwide. Here, we explore the cutting-edge technologies and methodologies defining this new era.
Read MoreAn intriguing discussion is going on in one corner of the world of clinical neuropsychiatry that has implications that are important for how a very common group of disorders are understood and, therefore, treated. ‘Functional disorders’ are conditions where physical symptoms and signs, after very thorough assessment, cannot be attributed to a general medical condition. Individuals with these conditions make up about 22% of all people presenting for primary medical care, and over 30% in some neurology clinics. The matter of debate is whether we know enough to attribute causation of these conditions to underlying psychological distress, or whether we should take an agnostic approach to causation.
Read MoreWelcome to an exciting new era in neurological care. Our upcoming Special Collection in SAGE Open Medicine, "Advances in Personalized Neurological Interventions: Bridging Transdisciplinary Insights," aims to be at the forefront of this evolution. We're at a unique point where advanced research intertwines with collaborative insights, and your contribution is crucial.
Read MoreAs Editor in Chief of the Journal of Geriatric Psychiatry and Neurology, I’m excited to announce the publication of a special issue on Emerging Neuropsychiatric Concepts in Parkinson’s Disease. Parkinson’s Disease (PD), the second most prevalent neurodegenerative disorder among older adults, currently affects more than 10 million persons in the world.
Read MoreCOVID-19 has transformed everyone’s lives globally. Early on in the pandemic, our research team became interested in the symptom of anosmia (loss of smell) as an early clinical feature of COVID-19 infection. “Why does this occur?” we wondered, and began exploring further to see if the virus impacted the brain, mental health or had consequences for pregnant women and newborns.
Read More
